Camden Capital »

Revance Therapeutics shares owned by Camden Capital

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Camden Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $53k 10k 5.19
2024-06-30 $26k 10k 2.57

More positions owned by Camden Capital

Citigroup Com New (C)
Ge Aerospace Com New (GE)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Onemain Holdings (OMF)
Morgan Stanley Com New (MS)
Micron Technology (MU)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
PNC Financial Services (PNC)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Camden Capital

Top funds holding Revance Therapeutics

BlackRock
Beryl Capital Management
Vanguard Group
Fil
Alliancebernstein
Squarepoint Ops
Magnetar Financial
State Street Corporation
Alpine Associates Management
Geode Capital Management
Boothbay Fund Management
Glazer Capital
Newtyn Management
Omni Event Management
Adage Capital Partners GP

View all funds holding Revance Therapeutics